Bd reports second quarter fiscal 2025 financial results

Revenue of $5.3 billion increased 4.5% as reported, 6.0% currency-neutral and 0.9% organic gaap and adjusted diluted eps of $1.07 and $3.35, respectively company updates full-year fiscal 2025 guidance and provides estimated tariff impact franklin lakes, n.j., may 1, 2025 /prnewswire/ -- bd (becton, dickinson and company) (nyse: bdx), a leading global medical technology company, today announced results for its fiscal 2025 second quarter, which ended march 31, 2025.
BDX Ratings Summary
BDX Quant Ranking